Manufacturing, Specialty Dosage Forms

October 21st 2022

Aragen’s new 12,000 ft² facility will include various dosage form capabilities, including oral solids, liquids, topicals, and films.

May 20th 2022

Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.

March 17th 2022

Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.

November 1st 2021

A coating technology for a staked needle prefillable syringe reduces the potential risks associated with silicone oil as a lubricant.